Dry eye disease (DED) is a multifactorial that represents one of the most common ophthalmologic conditions encountered in everyday clinical practice. Traditional diagnostic tests for DED, such as subjective questionnaires, tear film break-up time and Schirmer test, are often associated with poor reproducibility reliability, which make diagnosis, follow-up, management challenging. New advances i...

In October 2021, FDA announced the approval of Tyrvaya, a first-in-class medication to treat signs and symptoms dry eye disease. Tyrvaya is new formulation varenicline, drug used as smoking cessation aid. Unlike oral formulations, which are for cessation, nasal spray only treatment The Mayo Clinic defines disease “a common condition that occurs when your tears aren’t able provide adequate lubri...

Objectives: To investigate the efficacy and safety of a generic Cyclosporine 0.05% ophthalmic emulsion in chronic dry eye disease. Materails Methods: Thirty patients with disease were included this observational, prospective study. Patients examined at baseline, month -1,-3 6 The following evaluated each visit: CDVA (corrected distance visual acuity), corneal conjunctival staining (Oxford) scor...